Concepedia

Brent W. McCleland

BW

Statistics

Publications

8

Citations

306

H-Index

8

Active since

2004

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Brent W. McCleland is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, ligand binding, and pharmacology.

Publications per year

2004–2019

8

Publications

8

Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine Receptor

Katherine L. Widdowson, John D. Elliott, Daniel F. Veber et al. · Journal of Medicinal Chemistry · 2004 · 74 citations · Full text

, , +14

Discovery of Novel Cyanamide-Based Inhibitors of Cathepsin C

Dramane I. Lainé, Michael R. Palovich, Brent W. McCleland et al. · ACS Medicinal Chemistry Letters · 2010 · 52 citations · Full text

, , +15

Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor

Brent W. McCleland, Roderick S. Davis, Michael R. Palovich et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 37 citations · Full text

, , +12

Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor

Qi Jin, Hong Nie, Brent W. McCleland et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 37 citations · Full text

, , +14

Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema Model

Joseph E. Pero, Jay M. Matthews, David J. Behm et al. · Journal of Medicinal Chemistry · 2018 · 34 citations · Full text

, , +17

1–5 of 8